The relationship between body size and breast cancer still remains controversial in considering menopausal status.
Adult stature is determined by parents' stature, and is also an indicator of environmental factors such as energy intake during childhood and adolescence, especially in developing countries. 3 As breast malignant neoplasm has a long latency period, the influence of nutritional factors during childhood and adolescence, may play an important role. Puberty is characterized by intense cell mitosis and tissue growth, with increases in height and weight, and the development of breast tissue. The influence of the sex steroids as mediators of growth, as well as risk factors for breast cancer is well known. [4] [5] [6] Most case-control studies [7] [8] [9] [10] [11] and cohort studies, [12] [13] [14] [15] but not all of them, [16] [17] [18] [19] [20] have shown a positive association between height and breast cancer. Stature and breast size are positively related to the number of mammary cells, which are greatly influenced by energy intake and estrogen activity. 21 Girls that experienced early menarche are likely to be taller and overweight. 22 The influence of recent body weight on the risk of breast cancer appears to be controversial in relation to menopausal status. There is increasing evidence that obesity at the time of diagnosis and weight gain since youth increase the risk of breast cancer among postmenopausal women, 7, 8, 11, 16, 19, [23] [24] [25] although not confirmed by some other studies. 15, 18, 20 However, obesity has been shown to be a protective factor for breast cancer among premenopausal women in many studies, 5, 7, 9, 11, 14, 19, [26] [27] [28] but not all. 20 Over the last 20 years, the height distribution and the prevalence of overweight in the Brazilian population has been increasing, [29] [30] [31] which indicates that studies carried out in this population may be appropriate for investigating the association between body size and breast cancer.
This study evaluates the association of height, weight and weight changes with breast cancer, in a case-control study carried out in the city of Rio de Janeiro, Brazil, originally designed for testing the association between pesticides and other risk factors and breast cancer.
M E T H O D S
Women admitted to the main hospital of the National Cancer Institute (INCA, located in Rio de Janeiro), between May 1995 and February 1996 with a presumptive diagnosis of breast cancer made in the preceding 6 months were selected. Control subjects were identified from among female visitors to the same hospital during the same period of time. Cases and controls had been resident in the metropolitan region of Rio de Janeiro for at least 6 months and were aged up to 75 years. In the control group, women with a personal history of breast cancer were excluded. Controls were frequencymatched to cases according to 5- Cases and controls were interviewed at the hospital to obtain detailed information on demographic data, family history of breast cancer, menstrual and reproductive history and dietary habits and previous weight, including weight at ages 18 and 30 years and the maximum weight during their lifetime, excluding pregnancy periods. Cases were interviewed prior to surgical procedures to minimize the possible influence of knowledge of disease status. Anthropometric measurements were taken after the interview.
Height, current body mass index (BMI) (kg/m 2 ), BMI at ages 18 and 30 years, and maximum BMI, were categorized into specific quartiles for premenopausal and postmenopausal women and also treated as continuous variables. Weight changes since an early age were assessed by tertiles of weight gain, whereas weight loss was considered a fourth category. The single case aged 30 years was excluded from the analysis of weight loss from 18 to 30 years. Non-response was greater for weight between ages 18 and 30 years, but it was less than 17%. For maximum weight, the non-response was only 3.2%.
The odds ratios (OR) and 95 percent confidence intervals (95% CI) were calculated based on unconditional logistics regression adjusted for potential confounders, including age, age at menarche, parity, family history for breast cancer and education. Models were further adjusted for age at first full-term pregnancy and also smoking habits.
A reliability analysis of reported weights and height compared the current reported values with the measured ones.
RESULTS
Cases and controls were similar according to education level (P = 0.74). Cases were more likely to be nulliparous, or had low parity, or experienced their first birth after 30 years and had early menarche (Table 1) .
Height was not associated with breast cancer risk among pre and postmenopausal women. However, a non-significant trend of increasing risk with increasing height was observed among postmenopausal women (Table 2) . A trend towards increasing height in more recent cohorts of women is shown, as premenopausal women were 4 cm taller than postmenopausal women (P < 0.05), and they also experienced earlier menarche (median of 12.82 years vs. 13.09 years).
Among premenopausal women, breast cancer was negatively associated with current BMI (χ 2 for linear trend: P = 0.03) ( Table 2 ) and also with maximum BMI during life. Premenopausal women in the fourth quartile of the maximum BMI during life had a very low risk of breast cancer (OR = 0.15; χ 2 for linear trend: P = 0.008) compared to women in the lowest category (Table 3) . For postmenopausal women, no association was observed for any of the body size measurements.
Premenopausal women who experienced weight loss between ages 18 and 30 years and from 18 years until the present were at high risk of breast cancer compared to those in the highest tertile of weight gain (Table 4 ). Even after adjusting for smoking (data not shown) the significant association with weight change remained. Weight loss between ages 18 and 30 years ranged from 1 to 18 kg among premenopausal women. Among those women that lost weight between ages 18-30, no case was diagnosed before 33 years of age. Considering as weight loss only those women who lost more than 3 kg, the association was kept but it was not significant (P = 0.12) (data not shown). Premenopausal women who had lost weight between ages 18 and 30 years were on average 6 kg leaner at 30 years compared to their weight at 18 years. The risk of breast cancer for all anthropometric variables did not change significantly after adjusting for age at first full-term pregnancy. This was not included in all models because about 15% were nulliparous.
There was a high correlation between reported and measured weight. The intra-class correlation for weight was 0.98 for cases, and 0.95 for controls, whereas for height, the intraclass correlation was 0.92 for cases and 0.94 for controls.
DISCUSSION
In the present study, cases were more likely to be nulliparous, had low parity, experienced their first birth after 30 years of age, and had early menarche, in agreement with current literature, although no statistically significant differences were observed (Table 1 ). In addition, the family history of breast cancer was not different between cases and controls. Mendonça et al, 32 analyzing data from the same case-control study, reported a positive significant association with a family history of breast cancer, after excluding the twenty-seven controls visiting first or second degree relatives with breast cancer, which suggests that the lack of association may be attributed to overmatching. As family history of breast cancer was one of the variables selected for the multivariate analysis, we decided not to exclude those related controls.
Height was not significantly associated with increased risk of breast cancer among pre and postmenopausal women. In studies carried out in developed countries, taller women seem to be at high risk of breast cancer, 7-13 but other studies have not found this association. 14, 15 Results of studies on laboratory animals support the hypothesis that early energy restriction may decelerate height, delaying the onset of sexual maturation, and reducing the oncogene expression and tumor growth. 4, 33, 34 The lack of association between height and breast cancer in this study may be due to the fact that the Brazilian population is still shorter than the population in developed countries even with the increasing height that has been shown in Brazilian National Surveys. 28, 29 The fourth quartile value for height, for both pre and postmenopausal women in our study, is very close to the reference category in three prospective studies carried out in developed countries.
14,15,19 Also, premenopausal women in our study were four centimeters taller than postmenopausal women, and experienced earlier menarche, indicating an improvement in nutrition during growth periods over more recent years.
Our data agree with other findings 7, 9, 11, 14, 19, 25, 28 that obesity is inversely related to breast cancer risk among premenopausal women. Obese young women are more likely to have anovulatory and longer menstrual cycles, leading to low estrogen exposures of the breast cells 5, 27 and a decreased mitosis rate for the mammary tissue. 27 Obese young women also have low levels of progesterone, which seems to maximize estrogen action during the luteal phase. 35 There is also evidence that the body mass index before menopause is inversely related to serum level estradiol. 36 Leanness among young women is associated with high estrogen activity. [36] [37] [38] In contrast to most studies, 7, 8, 11, 16, 18, 19, 24 recent obesity and weight gain were not associated with breast cancer risk among postmenopausal women. Less variability of BMI among Brazilian women may explain this lack of association. The third and fourth quartiles of BMI in our study correspond to the fifth quintile in a population based case-control study carried out in the USA which showed evident association above the fifth decile of BMI. 7 After menopause, obese women have a high level of serum estrogen as a consequence of the conversion of androsteredione to estrone in the adipose tissue, and also due to decreasing concentration of the Sex Hormone Binding Globulin (SHBG), that increases the serum free-estrogen. 24, 27 The high production of estrogen may promote tumor growth, although the development of tumor growth depends on whether breast cell damage was replicated during the intense breast development, i.e., childhood and puberty period. As postmenopausal women in our study were shorter, they may have had a reduction in the mammary gland mass. 21 We did find a strong positive association for weight loss from age 18 to 30 and for weight loss from age 18 years until the present among premenopausal women. Weight loss was not a sign of preclinical disease, since the case diagnosed before 33 years (only one woman) was not included in the analysis. These weight losses may also not be due to smoking, as the results did not change after adjusting for smoking. To our knowledge, there are few studies relating weight loss to breast cancer risk. Recently, a casecontrol study reported a slightly non-significant reduced risk for weight loss from age 18 years until five years before the beginning of that study. 4 A cross-sectional study of 76 college women that underwent a restricted diet had a reduction in menstrual cycle length compared to those nondieters, 39 in accordance with other study. 40 Women with a short menstrual cycle may be at high risk of breast cancer because they spend relatively more time in the luteal phase, characterized by breast cell mitosis, than women with longer menstrual cycles. 41, 42 Harlow et al. 43 showed among 166 college women aged 17 to 19 years that overweight women were more likely to have a menstrual cycle longer than 43 days, whereas women who experienced loss of weight tended to reduce the length of cycles. Thus, weight loss may be associated with pre-menopausal breast cancer by shortening menstrual cycle length. There was no evidence of a differential misclassification among cases and controls related to reported weights and height in this study. The correlation coefficients for measured and self-reported weight and stature were up to 0.90 for both groups. In addition, error in reported body sizes would bias our risk estimations toward the null value.
Our findings showed a strong positive association for weight loss from age 18 to 30 and for weight loss from age 18 years until the present among premenopausal women, suggesting that obesity was inversely related to breast cancer risk among these women. These findings, with highest risk among those women with weight loss, may merely indicate the known association between leanness and breast cancer. Nevertheless, the small number of women losing weight in our study, as well as in many studies of breast cancer, makes it hard to confirm this possibility. Further studies should explore the role of weight loss on breast cancer risk. CONTEXTO 
